HIV Treatment Bulletin South

RSS Atom • ISSN 2046-9373 • Subscribe • About

Treatment access

• FDA approval of generic ARVs Treatment access - 28 February 2012

• Disastrous warning for global HIV programmes in 2012 Treatment access - 28 February 2012

• Michel Kazatchkine resigns from Global Fund: Gabriel Jaramillo, Brazilian banker, to serve as general manager Treatment access - 28 February 2012

• Janssen block Patent Pool access to darunavir, rilpivirine and etravrine Treatment access - 28 February 2012

• UNITAID continues funding the Patent Pool, paediatric HIV medicines and malaria Treatment access - 28 February 2012

• We need the Patent Pool to work Treatment access - 28 February 2012

• Call to Action on Global Fund restriction to new funding to 2014 Treatment access - 28 February 2012

• Analysis of why the Global Fund cancelled Round 11 Treatment access - 28 February 2012

• Reaction to the Global Fund’s decisions on Round 11 and grant renewals Treatment access - 28 February 2012

• FDA approval of generic ARVs Treatment access - 1 November 2011

• Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110/ESTER trials Conference reports - Treatment access - Treatment strategies - CROI 18 (Retrovirus) Boston 2011 - 15 August 2011

• DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells/mm3 could reduce unnecessary switching Conference reports - Treatment access - Treatment strategies - CROI 18 (Retrovirus) Boston 2011 - 15 August 2011

• Lopinavir/r monotherapy used as second-line therapy in resource-limited settings Conference reports - Treatment access - Treatment strategies - CROI 18 (Retrovirus) Boston 2011 - 15 August 2011

• FDA approval of generic ARVs Treatment access - 15 August 2011

• Gilead signs up for Medicines Patent Pool Treatment access - 15 August 2011

• FDA approval of generic ARVs Treatment access - 19 May 2011

• Global Fund reports rise in people on treatment Treatment access - 19 May 2011

• TRIPS agreement flexibilities provide opportunities for improved access to ARVs Treatment access - 19 May 2011

• Driving a decade of change: HIV/AIDS, patents and access to medicines for all Treatment access - 19 May 2011

• Virological findings from the SARA trial of boosted protease inhibitor monotherapy Antiretrovirals - Conference reports - Treatment access - HIV 10 Glasgow 2010 - 22 January 2011

• FDA approval of generic ARVs Treatment access - 22 January 2011

• ART distribution and adherence support by community groups in Mozambique Treatment access - 22 January 2011

• First-line ART outcomes: Trial finds nurses non-inferior to doctors Treatment access - 22 January 2011

• Cotrimoxazole prophylaxis reduces mortality in patients on ART with low CD4 counts or WHO stage 3 and 4 disease Treatment access - 22 January 2011

• FDA approval of generic ARVs Treatment access - 2 April 2010

• Waiting lists grow in the US Treatment access - 2 April 2010

• MSF criticise Abbott over new ritonavir formulation Treatment access - 2 April 2010

• More concerning research on the Free State ART programme Antiretrovirals - Conference reports - Treatment access - CROI (Retrovirus) 17 San Francisco 2010 - 6 January 2010

• FDA approval of generic ARVs Treatment access - 6 January 2010

• PEPFAR launches five-year strategy Treatment access - 6 January 2010

• Global Fund approves US$2.4 billion in new grants Treatment access - 6 January 2010

• UNITAID decision to fund ‘patent pool’ to boost access to new medicines Treatment access - 6 January 2010

• Factors affecting cost of ART: Data from Aid for AIDS Treatment access - 6 January 2010

• AIDS and mortality in South Africa Treatment access - 1 October 2009

• FDA approval of generic ARVs Treatment access - 1 October 2009

• Punishing success in tackling AIDS: funders’ retreat could wipe out health gains in HIV affected countries Treatment access - 1 October 2009

• Update on unmet need for HAART in South Africa Treatment access - 1 October 2009

• ARV Programme results reports at IAS Conference reports - Scale up - Treatment access - IAS 5 Cape Town 2009 - 1 October 2009

• Guidelines on when to start treatment in resource poor settings Conference reports - Guidelines - Treatment access - IAS 5 Cape Town 2009 - 1 October 2009

• AIDS medicine prices in the South African public and private sectors Treatment access - 1 July 2009

• TMC207 open label trial for MDR-TB TB coinfection - Treatment access - 1 July 2009

• FDA approval of generic ARVs Treatment access - 1 July 2009

• FDA approval of generic ARVs Treatment access - 18 April 2009

• HIV medicine prices in the South African private sector Treatment access - 18 April 2009

• FDA approval of generic drugs Treatment access - 22 January 2009

• Lost benefit of ARVs in South Africa Treatment access - 22 January 2009

• FDA approval of generic ARVs Treatment access - 22 September 2008

• Atripla to be licensed in Latin America and the Asia-Pacific region Treatment access - 22 September 2008